Cleveland BioLabs, Inc.

Cleveland BioLabs and Incuron Announce US and European Patent Allowances for Curaxins

BUFFALO, N.Y., May 14, 2013 (GLOBE NEWSWIRE) --

Cleveland BioLabs, Inc.

CORRECTION -- Cleveland BioLabs Reports First Quarter 2013 Financial Results and Development Progress

BUFFALO, N.Y., May 9, 2013 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Cleveland BioLabs, Inc. (Nasdaq:CBLI), the years in the column headers in the Consolidated Balance Sheets table were incorrect. With the exception of the headers, all other financials were correct. The corrected table follows:

Cleveland BioLabs, Inc.

Cleveland BioLabs Reports First Quarter 2013 Financial Results and Development Progress

BUFFALO, N.Y., May 9, 2013 (GLOBE NEWSWIRE) --

Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Appointment of Shareholder Representative to Board

BUFFALO, N.Y., May 8, 2013 (GLOBE NEWSWIRE) --

Cleveland BioLabs, Inc.

Cleveland BioLabs, Roswell Park Announce Publication of Studies Defining Role of Liver in Activity of Entolimod (CBLB502)

BUFFALO, N.Y., May 1, 2013 (GLOBE NEWSWIRE) --

Cleveland BioLabs, Inc.

Cleveland BioLabs to Report First Quarter 2013 Financial Results and Provide Operational Update on May 9

BUFFALO, N.Y., April 30, 2013 (GLOBE NEWSWIRE) --

Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Changes to Board of Directors

BUFFALO, N.Y., April 23, 2013 (GLOBE NEWSWIRE) --

Cleveland BioLabs, Inc.

Cleveland BioLabs Strengthens Clinical Development Team

BUFFALO, N.Y., April 8, 2013 (GLOBE NEWSWIRE) --

Cleveland BioLabs, Inc.

Cleveland BioLabs and Incuron Announce Notice of Allowance From FDA to Commence Clinical Testing With CBL0137

BUFFALO, N.Y., April 2, 2013 (GLOBE NEWSWIRE) --

Cleveland BioLabs, Inc.

Cleveland BioLabs Reports Fourth Quarter and Fiscal 2012 Financial Results and Development Progress

BUFFALO, N.Y., March 14, 2013 (GLOBE NEWSWIRE) --